Home › All Companies › BPTH

BIO-PATH HOLDINGS, INC. (BPTH)

AI-Powered SEC Filing Analysis

Current Report Filed: 2026-03-20

Key Insights

  • Bio-Path Holdings has completed its domestication to Wyoming, creating a new class of Series S Preferred stock with 51 authorized shares that are convertible to common stock and hold 1% of the diluted voting power.
  • The company has appointed two new members, Wendy M. Charles, PhD and Michael Hickey, to its Scientific Advisory Board, bringing expertise in clinical research, regulatory compliance, and oncology drug development.
  • The new Scientific Advisory Board members were granted 100,000 stock options each with a three-year expiration and $0.06 exercise price, indicating the company's commitment to incentivizing and retaining its advisory talent.
Sentiment: Positive Significance: 6/10
View Original Filing →
Current Report Filed: 2026-02-24

Key Insights

  • Bio-Path Holdings issued 51 shares of a new Series S Preferred stock and 2 million common stock warrants to its CEO's advisory firm, Steel Giants Advisors LLC, as payment for $10,000 in accrued consulting fees.
  • The company is undergoing a corporate domestication to move from Delaware to Wyoming, though the outcome and timing are uncertain.
  • Bio-Path is in discussions to restructure relationships with its payables and creditors, and intends to preserve drug supplies and seek shelf-life extensions, but success is not guaranteed.
Sentiment: Negative Significance: 6/10
View Original Filing →
Quarterly Report Filed: 2026-01-13

Key Insights

  • The company reported a decrease in research and development expenses from the prior year period, which could signal more efficient use of resources.
  • The company disclosed new financing arrangements with accredited investors, which may provide additional capital to support ongoing operations and development efforts.
  • The company's stock incentive plan was updated in 2022, potentially signaling a focus on retaining and incentivizing key personnel.
Sentiment: Neutral Significance: 5/10
View Original Filing →

Get real-time filing analysis in the app

Download on the App Store

Important Information

AI-generated analysis is for informational purposes only. Always read original SEC filings and consult with qualified professionals before making investment decisions.